Table 2.

Clinical characteristics of new TB infections occurring in patients with ankylosing spondylitis.

PatientAge, yrsTNF BlockerDisease Duration, yrsPeripheral ArthritisHLA-B27DMDMARDMean Steroid, mg/dayHistory of TBOld TB on CXRTSTProphylaxisInterval to Active TB*, moDiagnosis MethodTB Type
132 F25++MTX + SSZ2.5NDND228AFB (+)
CXR (+)
Pulmonary
245 M150++NDND132CXR (+)Pulmonary
331 M10+NDSSZ5NDND14CXR (+)Pulmonary
430 F10++SSZ0NDND36AFB (+)Pulmonary
543 M6++0NDND1CXR (+)Pulmonary
637 M6NDSSZ0NDND60CXR (+)Pulmonary
729 M3+SSZ0NDND15CXR (+)Pleurisy
845 F170NDND192TB-PCR (+)Intestine
941 M21++MTX + SSZ0NDND108CXR (+)Pulmonary
1030 M12ND1.25NDND96CXR (+)Pulmonary
142 MInfliximab17++MTX + SSZ5INH 9 mo177 (27)**CXR (+)Pleurisy
227 MInfliximab5++SSZ5ND41 (16)Chest CT (+)Miliary
327 MAdalimumab16+MTX + SSZ0++NDND186 (12)Chest CT (+)Pulmonary
  • * Interval between onset of AS and diagnosis of active TB.

  • ** ( ) Interval between starting TNF blockers and diagnosis of active TB. TB: tuberculosis; TNF: tumor necrosis factor; DM: diabetes mellitus; DMARD: disease-modifying antirheumatic drug; CXR: chest radiograph; TST: tuberculin skin test; MTX: methotrexate; SSZ: sulfasalazine; ND: not done; AFB: acid-fast bacilli; TB-PCR: polymerase chain reaction for M. tuberculosis; INH: isoniazid; CT: computed tomography scan.